Zen Koh Talks to NR Times About Fourier’s Global Expansions


Fourier Intelligence Co-Founder and Global Hub CEO, Zen Koh, speaks about the company’s headquarters relocation and future expansion into Europe and Australia

SINGAPORE, Nov 30, 2021 – Co-Founder and Global Hub CEO of Fourier Intelligence, Zen Koh, gave NR Times insights to the relocation of the company’s headquarters into the hugely sought-after ‘Silicon Valley of the East’ and its future expansion into Europe and Australia.

Fourier Intelligence will be taking a huge step forward in the company’s ongoing and significant expansion to further increase its prominence on a global scale through establishing new offices in Switzerland and Australia by the end of 2022. This expansion will be supported by some of the leading scientists and R&D leaders to help advance its research and product development even further – adding to its ten subsidiaries and joint research laboratories around the world. Other cities in the future plans of expansion are Chicago, Madrid, and London as well.

To read more about this interview, click here.

For investor and media inquiries, please contact:
Sarah Lim, Senior Manager
Fourier Intelligence
Phone: +65-6911-6651

UTAR and Fourier Intellience

UTAR and Fourier Intelligence Inks MoU to Advance in Rehabilitation Technology

UTAR and Fourier Intellience

Fourier Intelligence partners with UTAR to advance rehabilitation technology

SUNGAI LONG, Oct 1, 2021Aimed to facilitate research in rehabilitation technology, Universiti Tunku Abdul Rahman and Fourier Intelligence International Pte. Ltd signed a memorandum of understanding (MoU) via Zoom on 01 October 2021.

Under the collaboration, UTAR and Fourier Intelligence will work together to initiate joint projects involving collaborative research in the field of rehabilitation technologies.

The signing ceremony was held online to commemorate the collaboration between both parties. UTAR was represented by its President Ir Prof Dr Ewe Hong Tat and Fourier Intelligence was represented by its General Manager Mr Owen Teoh. Also present to witness the virtual signing ceremony were Fourier Intelligence Co-Founder and Global Hub Chief Executive Officer Mr Zen Koh, Fourier Intelligence Senior Manager for Business Development Mr Even Koh, Fourier Intelligence Senior Manager for Clinical Application and Research Ms Sarah Lim and Fourier Intelligence Senior Manager for Product Management Mr Jake Kee.

Staff from UTAR included Dean of Faculty of Medicine and Health Sciences (FMHS) Emeritus Prof Dr Cheong Soon Keng, Dean of Lee Kong Chian Faculty of Engineering and Science (LKC FES) Ir Prof Dr Goi Bok Min, FMHS Deputy Dean for Student Development and Industrial Training Assoc Prof Dr Leong Pooi Pooi, FMHS Head of Clinical Physiotherapy Programme K. Premala, LKC FES Asst Prof of Department of Mechatronics and BioMedical Engineering Dr Goh Choon Hian, Director of Division of Community and International Networking (DCInterNet) Assoc Prof Dr Lai Soon Onn, Director of Division of Corporate Communication and Public Relations Ong Soo Weon, Deputy Director of DCInterNet Dr. Chen, I-Chi, and UTAR staff.

Welcoming Fourier Intelligence into UTAR’s MoU fraternity of more than 500 international and local partners, Prof Ewe said that the collaborative initiatives explored through the MoU will be mutually beneficial to both parties.

“On behalf of UTAR, I would like to express my gratitude to Fourier Intelligence for giving us this opportunity to explore collaborations in the development of exoskeleton and rehabilitation robotics. Under this MoU, we will be able to facilitate exchanges of ideas and facilities, as well as industrial study visits of our students and staff, which is important for enhancing their learning experience and professional development. This will also enable us to gain insights into the industry, which is important for ensuring that our programmes remain relevant to the advances of the industry,” enthused Prof Ewe, who also expressed his delight that the MoU will allow FMHS and LKC FES to share knowledge and expertise, as well as establish possible collaborative research and development projects.

Lauding UTAR as a prominent and progressive university with enormous achievements, Mr Teoh said, “We are very honoured to be at this signing ceremony today and also look forward to working with UTAR to promote accessibility and adoption of rehabilitation technology.”

Signed MoU Documents between UTAR and Fourier Intelligence

Introducing Fourier Intelligence as a technology-driven company, infusing creativity into the development of exoskeleton and rehabilitation robotics since 2015, Mr Teoh added, “Throughout the last three years, Fourier Intelligence has established its installation of technology into 54 economies worldwide. We have also been signing MoUs and expanding our research collaborations with various renowned institutions in the world.”

“Today, we are very excited to partner with UTAR with the collaboration scope on developing talent, promoting education of rehabilitation technology as well as enhancing and collaborating in the research of engineering and technology development of rehabilitation and medical technology. With that, we believe that the impact that we are going to create would certainly contribute to the community and the health-care industry.” said Mr Teoh.

He continued, “With our extension office in Kuala Lumpur, we do look forward to working together with faculties in UTAR for the purpose of talent development, research and education as well as organise more webinars to promote awareness and also insights on rehabilitation technologies.”

The ceremony reached its highlight with the virtual presentation of the MoU documents signed by Prof Ewe and Mr Teoh.

Mr Owen Teoh of Fourier Intelligence and Prof Ewe of UTAR

About UTAR
UTAR is a university that offers courses in undergraduate and postgraduate programmes in the areas including Accountancy, Actuarial Science, Applied Mathematics, Arts, Chinese Studies, Malaysia Studies, Business and Economics, Biotechnology, Engineering and Build Environment, Information and Communication Technology, Life and Physical Sciences, Medicine and Health Sciences, Media and Journalism, Education and General Studies, Agriculture and Food Science, and engages in the provision and conduct of research, consultation, management and leadership training and other related educational services at its campuses at Bandar Sungai Long and Kampar in Malaysia.

For enquiries, please contact:
Division of Corporate Communication & Public Relations, UTAR
Ms. Saravani Selvam
Ms. Caryn Ng

For investor and media inquiries, please contact:
Sarah Lim, Senior Manager
Fourier Intelligence
Phone: +65-6911-6651

Fourier Intelligence Leaves a Major Impression at RehabWeek 2021

Fourier Intelligence participated in this year’s RehabWeek Virtual 2021 which was held on 23-25th September as the platinum sponsor

SINGAPORE, Sept 25, 2021Fourier Intelligence left a great impact as the platinum sponsor in the RehabWeek 2021 which was held virtually from September 23-25th. RehabWeek is a top event in the international rehabilitation field which is held every two years and is well known as the “Olympic Games” in the rehabilitation industry. During the event this year, Fourier unveiled its ArmMotus™ EMU, a 3D upper limb rehabilitation robot for the first time.

In addition to that, Dr Minos Niu Chuanxin of Ruijin Hospital, an affiliate to Shanghai Jiaotong University and Professor Jose Pons of Shirley Ryan AbilityLab also delivered keynote speeches during the symposium. Co-Founder and Global Hub CEO of Fourier Intelligence, Zen Koh also participated in a roundtable discussion session, ‘Meet The Entrepreneurs’, to discuss and demonstrate the advanced nature of rehabilitation medical technology in China and globally.

As the leading conference in the field of rehabilitation, the RehabWeek brings together top engineers, clinicians, researchers, and industry representatives from all around the world, providing the best platform for networking and meaningful interactions. Previously held in Zurich and London, the pandemic has forced the event to be held virtually this year. The conference was jointly hosted by the International Consortium for Rehabilitation Robotics (ICORR), the International Functional Electrical Stimulation Society (IFESS), the International Industry Society in Advanced Rehabilitation Technology (IISART) and the International Society for Virtual Rehabilitation (ISVR). Experts were invited to share their academic researchers, industrial insights, clinical findings as well as to discuss the latest development trends and innovative ideas in the rehabilitation industry.

Fourier Intelligence Launches ArmMotus™ EMU

During the first day, Fourier Intelligence unveiled its new device, the ArmMotus™ EMU, a 3D upper limb rehabilitation robot. Being the world’s first 3D back-drivable upper limb rehabilitation robot, The ArmMotus™ EMU was jointly built by Fourier Intelligence and the University of Melbourne Robotics Lab. It has successfully transformed years of scientific research into a clinically proven device that redefines human-machine interaction. The ArmMotus™ EMU has a large 3D training trajectory motion that combines with the industry-leading force feedback technology. This will simulate the force exerted by a therapist and allows rehabilitation movement to be more realistic.

Zen Koh, the Co-Founder and Global Hub CEO of Fourier Intelligence emphasized the importance of this device launch. “The appearance of the ArmMotus™ EMU in the RehabWeek is not only a huge benchmark for intelligent rehabilitation devices but also personally a huge milestone for us.”

“It has been a project that we have worked on for years and we are proud to finally show the fruits to our labour. We were looking to provide users with not only a complete but easy-to-use upper limb robotic rehabilitation device and the ArmMotus™ EMU is the answer”, said Zen Koh.

Meeting the Entrepreneurs

Zen Koh, the ambassador of The International Industry Society in Advanced Rehabilitation Technology (IISART), was invited to a roundtable discussion during the RehabWeek to share his 20 years of experience in the industry. “In addition to providing services to existing markets in China and Asia, Fourier intelligence have our focus set on expanding in North America and Europe. The next step will be to possibly set up a branch in Zurich, Switzerland to further expand our influence in the European market. We may also establish additional branches in Chicago and Melbourne next year. Our aim is to serve the world”, said Zen Koh.

Zen also pointed out that for a product to truly enter the mainstream market, it must have three important elements: people, money, and space. “The robot is just like a car. Fourier Intelligence has made the leap from manual to automatic. Fourier devices are highly operative and allow therapists to train multiple patients at the same time, which perfectly solves the problem regarding the shortage of therapists.”

“In terms of pricing, we are not looking to manufacture the Ferrari of rehabilitation robotics, but products that everyone can afford. Relying on core technology developed by independent research and development, coupled with the ecological synergy of upstream and downstream industrial chains, Fourier devices are created. The quality of devices is on par with the ones manufactured in Europe and the United States, but the price is only about one-third.” said Zen Koh.

“Lastly, space is also another major pain point of rehabilitation. Spaces in hospitals are very valuable. If the device is reliable but takes up a huge space, it would still not be desirable”. Fourier Intelligence has solved these pain points and has been very well received by the market, installing over 1000 devices globally in only the span of 3 years.

Future of Interconnected Rehabilitation

Prof Jose Pons of Shirley Ryan AbilityLab gave a presentation titled ‘Towards a Digital Continuum of Care Model: The Role of Robotics’. Prof Jose Pons talked about the two typical paths of the continuum of care for neurological models and gave his opinion on suggested rehabilitation training programs. He also mentioned the importance of rehabilitation robotics in supporting group interventions and remote interventions, especially during these pandemic times. “We believe that the usage of robotics or AI can use to break the physical barrier between therapists and patients, and they can be mediators between the caregivers and patients in the digital CCM. This will provide more intense training and interventions can be more personalized to the motor and cognitive status of patients as well”.

In another keynote lecture, Dr Minos Niu Chuanxin from Ruijin Hospital, Shanghai Jiaotong University School of Medicine, shared the challenges faced by rehabilitation robots in clinical settings. As an emerging technology, rehabilitation robots face difficulties in being clinically verified for their actual application effects. Led by Ruijin Hospital, a large-scale randomized double-blind grouped controlled experiment of rehabilitation robotics was carried out and after three years of research, some clinical effects have been accumulated. Dr Minos pointed out that although each country has its own regulatory system, the scientific research of rehabilitation knows no borders. “Although we come from different nationalities, our body functions are similar. Researchers use the same scientific research system and discourse to produce results and evidence that can be recognised mutually.”

“The open robotic technology platform created by Fourier Intelligence has broken the technological barrier of rehabilitation robotics, encouraging cooperation and openness, rather than just relying on the ideas from one source”, said Dr Minos. He also spoke about the importance of industry-university-research-medical integration, stating that medical products need the cooperation and promotion of clinics and enterprises to be successful.

For investor and media inquiries, please contact:
Sarah LIM, Senior Manager
Fourier Intelligence
Phone: +65-6911-6651

Fourier Intelligence Launches 3D Upper Limb Rehabilitation Robot, ArmMotus™ EMU

The ArmMotus™ EMU was officially unveiled and launched by Fourier Intelligence during the RehabWeek 2021

SINGAPORE, Sept 23, 2021 – Fourier Intelligence officially launched the new ArmMotus™ EMU during the RehabWeek 2021 that was held virtually this year from September 23rd to 25th 2021. The launch was attended by clinicians, researchers, engineers, and other stakeholders in the rehabilitation technology field.

The ArmMotus™ EMU is the world’s first 3D back-drivable upper limb rehabilitation robot, setting a new benchmark for intelligent rehabilitation devices. With it being a multifunctional, immersive, end-effector based 3D upper limb rehabilitation robot, the ArmMotus™ EMU brings a whole new experience of robotics rehabilitation therapy to the world.

The design of the ArmMotus™ EMU has redefined the human-machine interaction. It is the first of its kind that applies the end-effector based concept into the 3D movement, which makes it multifunctional and transparent. This transparency starts with a cable-driven mechanism, that combines with a 4-linkage structure, which perfectly reduces the friction and inertia during the movement of the system. This design also enables the control system to respond and execute more efficiently.

The ArmMotus™ EMU, which was jointly built by Fourier Intelligence and the University of Melbourne Robotics Laboratory, was a project in the making for the past 2 years that was led by Professor Denny Oetomo. “The robot offers large workspace with very minimal resistance and reflected inertia of the robot on the patient. This would allow the patient to move freely”, said Prof. Oetomo.

“Combined with the appropriate gravity compensation of the weight of the arm, patients with weak or little arm function, is able to carry out therapy without exertion.”, said Prof. Oetomo.

Another key person to the success of the ArmMotus™ EMU, Dr Marlena Klaic, who is the translational research lead of the Royal Melbourne Hospital, gave some insights into why robotic rehabilitation is important. “There’s a large and growing body of evidence suggesting that robotic devices can improve a patient’s outcome, including function, strength and ADL”.

“This evidence is growing even more rapidly in these pandemic times as more people are exploring digital and remote prevision therapies.”, said Dr Marlena.

“We conducted a user-based design study where we build and modify the robot based on the feedback from clinicians. Based on our results, we found that clinicians believe that robotic devices can be helpful in their practice. Patients and junior therapists are more frequently asking for robotic devices as part of their therapy session.”, said Dr Marlena.

Aside from exoskeleton and other one-dimension upper limb rehabilitation robots, EMU is based on terminal control and high technical content which is difficult to develop. It is China’s first breakthrough in this field. EMU uses the industry-leading force feedback technology platform, which was independently developed by Fourier Intelligence, to simulate the force exerted by a therapist. EMU also provides a large 3D trajectory training space which allows rehabilitation movements to be more realistic and guides users to complete various complex rehabilitation training.

During the product video presentation, EMU can be seen to support dual upper limb cooperative and mirror training, which further enriches the rehabilitation training program. Product director of Fourier Intelligence, Daris Yang also explained the importance of having interactive rehabilitation programmes. “By equipping EMU with games such as table tennis, cooking, and fishing, this would simulate activities of daily living even more”, said Yang. “The boring and repetitive training actions in traditional rehabilitation makes it boring for patients to train for a long time. Our EMU game settings have completely rewritten the rehabilitation scene”.

Zen Koh, Co-Founder and Global Hub CEO of Fourier Intelligence, believes that the ArmMotus™ EMU is instrumental in changing the future of neurorehabilitation. “Current neurorehabilitation models primarily rely on extended hospital stays or regular therapy sessions which require close physical interactions between rehab professionals and patients. The ongoing COVID-19 pandemic situation has challenged this model and as a result, many neurological patients are not receiving sufficient therapy. There is an urgent need to rethink conventional neurorehabilitation therapy.”

“The new ArmMotus™ EMU provides that solution. The EMU, equipped with clinical intelligence, provides personalised therapy, technology-based solutions, coaching capabilities and remote monitoring.”, said Zen Koh. “The implementation of fun functional games with embedded artificial intelligence also provides clinically motivating therapy to patients as well as giving caregivers and healthcare practitioners confidence”.

For investor and media inquiries, please contact:
Sarah LIM, Senior Manager
Fourier Intelligence
Phone: +65-6911-6651

Zen Koh Appointed as Global Committee Chair for DLC, World’s Leading Business Platform

Zen Koh, Co-Founder and Global Hub CEO of Fourier Intelligence, appointed as chair for DLC Health and Wellness committee to represent the Singapore Chapter

SINGAPORE, Sept 21, 2021Della Leaders Club (DLC) officially appoints Zen Koh as Global Committee Chair of the Health and Wellness committee during a virtual launch of the committee event. The purpose of this appointment is to provide leadership and knowledge in healthcare solutions and services for people with disabilities.

The virtual event also witnesses appointments and introductions of other Health and Wellness committee members of DLC. This virtual event was attended by all the committee members of the Health and Wellness group across the globe.

This decision by DLC to appoint Zen as part of the committee was to award him for his past achievements and strongly believe that the appointment will greatly benefit society. With 20 years of extensive experience in the healthcare industry, Zen consults regularly with executives from a variety of fields to help create synergistic solutions. Zen was also nominated by MD+DI amongst the top 40 under 40, the future most influential industry in med-tech, recognising his contribution in developing novel technologies and leading companies that will transform the future of the healthcare system.

Zen’s appointment in July 2020 as the inaugural ambassador for the International Industry Society in Advanced Rehabilitation Technology (IISART) for his contribution towards advancing advanced Med-Tech and Robotics for Rehabilitation further cements this decision.

“This is a privilege for me personally to be part of DLC. It is uplifting to know that my achievements have been recognised and awarded with this appointment,” says Zen Koh.

“I am looking forward to sharing my knowledge and experience in the health care industry at the highest level as part of the Health and Wellness global committee chair. My role here is to provide the members with filtered business knowledge and experiences that will cater to their unique challenges.”

“I strongly believe that DLC has a lot of potential and influence globally to do so and I am proud to be part of it”.

Zen Koh, alongside committee members from Sir H.N. Reliance Hospital & Spark Healthcare, will be involved to promote healthy habits among the public as well as improving the cost of city healthcare infrastructure. During these times of pandemics and lockdowns, this committee will also seek to help members with their physical and mental health.

DLC is the world’s 1st business platform, comprising entrepreneurs, professionals, and young leaders from all around the world to positively impact the world. With the mission to create a global community of transformative leaders who want to re-invent industries and re-boot societies, DLC offers forums, brand collaborations, global summits and DLC knowledge to assist in building a world that is better, stronger, and kinder.

“I wanted to positively impact the global business community in these unprecedented times”, said Jimmy Mistry, Founder & CEO of DLC. “This led to the conceptualization of DLC”.

With committee members from various regions around the world and plans to grow to countries such as Spain, China, Germany, and Japan, DLC will certainly leave a stronger mark in the years ahead.

For investor and media inquiries, please contact:
Sarah LIM, Senior Manager
Fourier Intelligence
Phone: +65-6911-6651

Tech Start Up Fourier Intelligence Nabbed the “Shanghai Design 100+” for 2020-2021

Fourier Intelligence’s Lower Limb Exoskeleton, the ExoMotus™ M4, awarded the “Shanghai Design 100+” Award from the Shanghai Municipal Commission of Economy and Information Technology for 2022-2021 

SHANGHAI, May 29, 2021 – Fourier Intelligence, a top rehabilitation industry leader, has won the “Shanghai Design 100+” award for their coveted lower limb exoskeleton, the ExoMotus™ M4.

This marks the second year for the “Shanghai Design 100+” awards ceremony hosted by the Shanghai Municipal Commission of Economy and Information Technology. The ceremony was held in the central plaza of Shanghai Shangsheng Xinsuo and was attended by many other companies, including those in design.

To further promote the influence of Shanghai’s designers, the Shanghai Municipal Commission of Economy and Information Technology encourages innovation and creativity through the “Shanghai Design 100+” awards. In the recent 2020-2021 event, Fourier Intelligence was among the total of 1,541 design products, design events, and design cases collected.

The number of participations far exceeds the previous year. Design companies in the Yangtze River Delta, Beijing-Tianjin-Hebei, and Pearl River Delta actively partook for the award.

The awards ceremony was attended by 920 designers and design teams, covering over 30 industries, 100 review experts, with over 2.45 million public online votes and 15.35 million online clicks. 287 achievements were shortlisted, and sales of 25.91 billion yuan have been achieved, and total sales are expected to be 370.18 billion yuan. The “Shanghai Design 100+” awards were conferred after a thorough evaluation from a mix of industrial votes, key expert votes, and public voting.

Some Participants of the “Shanghai Design 100+” Awards

In this annual event, the ExoMotus™ M4 gait and body weight support system launched by Fourier Intelligence won the “Shanghai Design 100+” in 2020-2021. The exoskeleton is by far the first and only exoskeleton in the market with its own body weight supporting system.

Fourier Intelligence’s ExoMotus™ M4

The ExoMotus™ M4 lower limb rehabilitation robot adopts an integrated ergonomic design, is user-friendly, and can achieve gait functional training and multiple mode evaluations. The gait mechanical leg can provide the user with precise sensory input in the early stage of rehabilitation through repetitive walking and inhibit the formation of an abnormal gait pattern or learned non-use. Early gait training on the ground enhances plantar activation and biofeedback. Moreover, dynamic balance and symmetrical weight-bearing assessments can be performed before and after training, which provides a quantitative reference for measuring the outcome and progress of gait training with this futuristic assistive technology.

In addition to having multiple training modes and adjustable parameters, having the additional balance assessment and training modules are the three main characteristics of this lower limb rehabilitation robot that is designed to empower gait training. Through this feature, users can have personalised rehabilitation training.

The ExoMotus™ M4 will be launched into the Chinese market at the Shanghai GReAT 2021 annual summit at the end of July. The launch of this product into the international market is expected to be in early 2022.

Fourier Intelligence is recognised globally for its innovative and intelligent solutions that are based on independent research and development of core rehabilitation robot technology, providing medical institutions and patients with the world’s leading comprehensive advanced rehabilitation solutions. At present, the company has strategic partnerships with nearly 20 top universities and research institutes around the world to jointly develop progressive rehabilitation technologies and promote the application of rehabilitation robotics at the international level. Some of these partner institutions include the Shirley Ryan Ability Lab in Chicago, KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network, ETH Zürich in Switzerland, National Healthcare Group in Singapore, and the University of Melbourne. Fourier Intelligence has over 1,000 installations in hospitals and institutions with a global presence in more than 50 countries and regions around the world.

For investor and media inquiries, please contact:
Sarah LIM (Senior Manager)
Fourier Intelligence
Phone: +65-6911-6651

The KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network and Fourier Intelligence announces Global Partnership

Virtual MOU signing event between KITE and Fourier Intelligence (FI).

(Top row, from left): Mr Zen Koh (Co-Founder, Group Deputy CEO), Dr Milos Popovic (Director of the KITE Research Institute), Prof. Denny Oetomo (Co-Director University of Melbourne & Fourier Intelligence Robotics Lab)

(Bottom row, from left): Sarah Lim (Clinical Application Specialist, FI), Taya Hamilton (Clinical Application Consultant, FI), Sophia Li (Partnerships & Strategic Project Manager, KITE)

The KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network and Fourier Intelligence to jointly develop a new world-class Rehabilitation Robotics Centre

CANADA & SINGAPORE, Dec 18, 2020 – The KITE Research Institute at the Toronto Rehabilitation Institute – University Health Network and Fourier Intelligence have formed an important global partnership by signing a Memorandum of Understanding (MOU). The two parties are pleased to announce they have entered a global partnership to expand KITE’s robotics research and education capabilities including the establishment of a new world-class Rehab Robotics Centre with Fourier’s next-gen RehabHub™ and support from its network of researchers. A virtual signing event took place on Dec. 16.

Fourier’s next generation RehabHub™ Robotics and central patient management system.

The research at UHN will be conducted by KITE, the No. 1 ranked Rehab Research Facility in the world, and one of the principal research enterprises at Canada’s top research hospital network, UHN.

The announcement of this partnership is timely, given the impact of the COVID-19 crisis and society’s changing attitudes on the adoption of home-based rehabilitation technologies and telerehabilitation. The KITE-Fourier partnership brings together clinicians, researchers, and engineers in technology development to further propel the field of rehabilitation robotics/technologies and help support users through successful healthcare technology integrations.

The MOU was co-signed by Dr. Milos R. Popovic, Director of the KITE Research Institute, a pioneer in the field of bioengineering and assistive technologies and Zen Koh, Fourier Intelligence’s Co-Founder, Group Deputy CEO.

“Zen and I have been acquainted for many years, and it is great to finally come together in a collaboration to realize what we have both been discussing for the past few years,” said Popovic, who is also a professor with the Institute of Biomedical Engineering at the University of Toronto. “Fourier is a great partner and this agreement will help us achieve KITE’s vision of developing a new world-class Rehab Robotics Centre. We are currently in the process of raising $12 million to get this Rehab Robotics Centre up and running.”

Dr Milos R. Popovic, Director of the KITE Research Institute.

“We are excited about this partnership. KITE, under the leadership of Milos, is considered one of the top global research facilities in the field of rehabilitation,” said Zen Koh, Fourier Intelligence’s Co-Founder, Group Deputy CEO. “Working together, we can consolidate our resources and jointly design and develop next-generation technologies for our clinicians and patients.”

Mr Zen Koh, Co-Founder, Group Deputy CEO, Fourier Intelligence.

The MOU coverage focuses on the field of, among others, robotics rehabilitation research, the formation of a joint lab with Fourier Intelligence’s multitude of institutional research labs and a regional education centre. Professor Denny Oetomo, who is leading the University of Melbourne & Fourier Intelligence Robotics Lab, was also present during the virtual signing ceremony. “We are thrilled to be able to work with KITE as they have well-integrated engineering and clinical testing,” added Oetomo.

To further strengthen the partnership, KITE will also join Fourier’s Global Rehabilitation and Assistive Technology Network (GReAT) Network, to optimize resource sharing and promote translational research of rehabilitation technology into clinical practice.

Fourier Intelligence’s RehabHub™

About University Health Network Toronto Rehabilitation Institute
Toronto Rehabilitation Institute is the largest rehabilitation hospital in Canada, and a member of the University Health Network. The research arm of the Toronto Rehabilitation Institute, KITE, is a world leader in complex rehabilitation science and is dedicated to improving the lives of people living with the effects of disability, illness, and ageing. KITE is one of the principal research enterprises at the University Health Network (UHN), Canada’s top research hospital with more than $350 million in total annual research expenditures.

UHN Media contact
Jarrett Churchill
Senior Advisor, Public Affairs and Communications
KITE | University Health Network

For investor and media inquiries, please contact:
Zen Koh (Group Deputy CEO/Chief Strategy Officer)
Fourier Intelligence
Phone: +65-9338-2328


Fourier Intelligence Launches The New LineMotus™ L1


LineMotus™ L1 will be the new lightweight and portable upper limb rehabilitation robotics

BEIJING, Nov 27-29, 2020 – 4th Chinese Association of Rehabilitation Medicine Annual Conference and International Rehabilitation Equipment Expo was held at the Beijing National Convention Center. Fourier Intelligence participated in the exhibition and released a new product, LineMotus™ L1 which is an intelligent linear motion training robot to empower the health care institutions in the elementary level.

LineMotus™ L1 inherits the design concept of “Less is more”. It simplifies the tedious upper limb rehabilitation exercises yet achieves point-to-point repetitive linear motion. The device is designed to be light and portable, easy to install, and suitable for a variety of rehabilitation methods

Thanks to LineMotus™’s streamlined and compact structural design, users can adjust to a variety of training positions to achieve their rehabilitation goals. Users can also combine multiple devices to achieve complex exercise training such as shoulder joint adduction and abduction, elbow joint flexion and extension, and pushing-pulling motion.

With gamification training methods, multi-sensory interactive feedback can be achieved. With the immersive and interactive experience, users can have visual-audio feedback. The built-in mechanics of the interactive games are very much suitable for elderlies in the community health centre to train their muscle strength, control, and reaction.

LineMotus Games
Therapy games provided by the LineMotus L1

With the Fourier Intelligence’s advanced device interconnection technology, multiple devices can be interconnected and interacted in real time. This can be implemented to both single and double upper limb training or group training, which gives LineMotus™ L1 its uniqueness when it comes to rehabilitation training.

Adhering to the fine tradition of Fourier intelligent rehabilitation robots, LineMotus™ L1 uses a new independently developed motion control card and high-performance motor to fully upgrade the core force feedback algorithm to achieve precise force control. The built-in high-precision sensor ensures that the whole training process is quantifiable.

It supports a full set of training modes such as active, passive, assistive, and resistance. It also provides personalised programs for various training such as motion control, muscle strength, and cognition, which covers the needs of the entire rehabilitation period.

Alex Gu Jie, CEO of Fourier Intelligence, mentioned that in the entire Fourier Intelligence RehabHub™ concept, LineMotus™ L1 is an entry-level linear motion training robotic device. The adoption of robotics at all level speeds up the coverage of intelligent rehabilitation system and promotes the abundancy of the industry hence bringing more intelligent technology into daily life. This allows more elderly people to enjoy intelligent rehabilitation services.

Fourier Intelligence Raises 100 Million RMB in Series C Financing Round

The company has completed a new Series C Financing round to fund and accelerate investment in research and development, sales and support

SHANGHAI, Oct 23, 2020 – Fourier Intelligence announced it had completed its Series C financing round led by Vision Plus Capital, a leading venture capital fund focusing in digital healthcare and deep tech. Qianhai FOF, one of Fourier Intelligence’s current shareholder, co-invested in this round as well. This new round of funds will be mainly invested to further expand Fourier Intelligence’s already impressive product line, to enhance its fully integrated intelligent rehabilitation robotic system, known as the Fourier Intelligence RehabHubTM Concept.

“The intelligent rehabilitation has been possible since the advent of the digital and intelligence era. Artificial Intelligence (AI) is the developing trend of the rehabilitation field while the viability of Fourier’s business model has been verified,” says Fourier Intelligence’s Founder, Group CEO and Executive Chairman Alex Gu. “Our investors fuel momentum into the company, which will further iterate and replicate the products to enter a high-growth period. We aim to form an industry-driven platform to achieve the strategic vision of Robotics for All.”

Fourier Intelligence’s Founder, Group CEO and Executive Chairman, Alex Gu

“As if the central kitchen that enables the restaurant industry to realise chain operations across the country and even globally, the standardisation of clinical rehabilitation protocols will also support the development of rehabilitation departments that deliver positive clinical outcomes consistently. Our target is to enable 50-100 thousand rehabilitation facilities globally through our RehabHubTM Concept, and eventually provide quality rehabilitation services to millions of elderly, paediatric, and neurological patients,” he claimed.

Headquartered in Shanghai and with offices in Singapore, Malaysia, Guangzhou and Zhuhai, Fourier Intelligence is an innovative global technology company dedicated to researching, manufacturing, and marketing of rehabilitation robotics and comprehensive intelligent solutions.

Founded in 2015, the company has teamed up with experienced researchers, engineers, and medical specialists to develop the complete rehabilitation system to serve hospitals, communities and patients.

“We are excited about this collaboration with Fourier Intelligence, and we are confident that this investment will serve as the catalyst that will further fuel the already excellent growth trajectory Fourier Intelligence has been experiencing for the past two years. With its sterling track record in developing innovative, clinically applicable fully-integrated rehabilitation solutions as well as delivering proven rehabilitation medical services to create a complete rehabilitation ecosystem,” says Tian Min, partner of Vision Plus Capital.

She adds that “Rehabilitation is an important and vastly underrated industry segment with huge market potential. We are fully convinced that Fourier Intelligence is well-positioned to lead this trending industry globally, with its proven technology solution system (RehabHubTM), which consists of robotics, AI, big data, cloud-based patient management systems, and clinical service delivery model.”

“Fourier Intelligence has achieved encouraging growth and positive developments over the past years. More than 1,000 hospitals and research institutes have successfully installed technology solutions developed by Fourier Intelligence, across 30 countries worldwide. To ensure continuous technological innovation, Fourier Intelligence has established several joint research labs. Such as the Shirley Ryan AbilityLab based in Chicago, the ETH Sensory Lab based in Zürich and the Advanced Robotic Lab based in the University of Melbourne. Such strong global research networks are rare within our industry and is key towards our success.” says Fourier Intelligence Co-Founder, Group Deputy CEO, and Chief Strategy Officer, Zen Koh.

Fourier Intelligence Co-Founder, Group Deputy CEO, and Chief Strategy Officer, Zen Koh

Recent studies indicate that rehabilitation resources are incredibly scarce and unevenly distributed across China. The shortage of rehabilitation therapists are known to be as high as 300,000, and there is a severe lack of rehabilitation service capacity. Current practices are human-intensive and lack efficiency. It is estimated, just China alone, the anticipated market size for rehabilitation and its related industry exceed 100 billion RMB.

To address this significant shortfall, Fourier Intelligence launches the RehabHub™ Concept, aiming to improve the adoption of rehabilitation robotics and technologies in rehabilitation facilities. The RehabHub™ Concept will improve efficiency and efficacy and transform the conventional rehabilitation approach.

Fourier Intelligence’s RehabHub™ Concept

For investor and media inquiries, please contact:
Mr Zen Koh (Co-Founder / Deputy CEO / Chief Strategy Officer)
Fourier Intelligence
Phone: +65-9338-2328


Chinese Startup Reinvent The Exoskeleton

For the 85 million disabled in China, obtaining a set of rehab exoskeletons is a far-off dream. The futuristic product, which promises greater flexibility and independence, can cost as much as half a million U.S. dollars. Considering that the average disposal income per capita in 2018 was RMB28,228 (US$4,155) in China, one would need to save 120 years of income to afford the equipment.

No wonder a slew of startups have attempted to create cheaper products to tap into this potentially massive and lucrative market. One of them is Fourier Intelligence, a Shanghai-based company backed by Chinese investors including IDG Capital and Shenzhen Qianhai Fund of Funds. But the path toward helping the disabled walk is full of daunting challenges.

“The real hurdle for us is that exoskeleton is not being widely used,” said Zen Koh, managing director of Fourier Intelligence, during a phone interview with China Money Network in January. “The main reason is the technological constraint: None of the known 165 companies, laboratories, and research institutions working on exoskeletons can build a product that can be worn on a daily basis for hours. Imagine you buy a several-hundred-thousand-worth device, but you still need to walk around with crutches, then what is the purpose?”

This creates a vicious circle, in which low usage and high price keep most consumers watching on the sidelines. It in turn leads to the inability to scale. What Fourier Intelligence wants to do is to make products at the price level of around US$20,000, eventually lower it to just a few thousand, making it affordable to all disabled.

At the same time, Fourier Intelligence, drawing its name from the French mathematician Joseph Fourier, is tweaking its products to suit the real needs of users. Its next-generation rehab exoskeleton product “Fourier X2” is designed to assist lower limb rehab for stroke patients and other victims of mobility impairment. The new product, being only one third as expensive as standard exoskeletons in the market, is equipped with a self-developed active motion control system. The system includes four power units and six multi-dimensional mechanical sensors installed near thighs, shanks and soles to read and react to users’ movement intentions. In comparison, most products in the market are based on predetermined programs of the exoskeletons to guide users’ movements.

Fourier Intelligence introduced its next-generation rehab exoskeleton product “Fourier X2” on January 21 to assist lower limb rehab for stroke patients and other victims of mobility impairment.

Zen Koh started serving as deputy CEO of Fourier Intelligence since June 2018. Prior to his current position, Koh was the managing director for Hocoma and the Assistant Chief Executive (ACE) for the Singapore National Co-operative Federation (SNCF), which is one of the apex bodies of cooperatives in Singapore.

Below is an edited version of the interview.

Q: How is the development of the exoskeleton market in China now?

A: I think the Chinese market is huge for exoskeleton because Chinese people are very receptive to new technologies. However, the race in the Chinese exoskeleton market hasn’t even started. I think we are at the exploratory phase.

I hate to say that I think a lot of companies are playing the role of a follower. They study what has been done around the world and try to make it better, cheaper and faster. In my observation, I feel that a lot of people do not know what exoskeleton products they are building and who/why they are building for.

This is dangerous. It’s a bit like reinventing the wheels. We are using the same resources – limited resources, and patience of consumers – to do the same thing again and again. It’s not surprising to me that the exoskeleton market is losing money.

And not just Chinese companies, many international companies build their products based on the latest and most “sexy” technologies available. Then they try to find or justify the needs for the patients. Look at the most successful exoskeleton companies in the world, like California-based Ekso Bionics, their share prices have been dropping for three years or five years till now.

Q: How should the Chinese exoskeleton industry innovate?

A: At this stage, exoskeleton developers, which are also generally known as robotic companies, will have to conduct research and development based on their experience in the market to meet the real needs of target customers. Our suggestion is to have a good understanding of the field. Then understanding our strength and using it to develop solutions for that field.

Fourier believes in identifying the purpose of the technologies to be developed. We work closely with clinicians and patients to understand users’ real needs.

Q: There are a lot of exoskeleton products in the market, which are usually priced at between US$70,000 to US$200,000. Is this price range suitable for consumers in China?

A: You must look at this question from two different angles. First, the price is high for sure. But if exoskeleton can help a person stand up and walk again, it is not expensive. The real challenge for us is that exoskeleton is not being widely used, due to technological constraint, price, and usability.

The main reason is the technological constraint: None of the known 165 companies, laboratories, and research institutions working on exoskeletons can build a product that can be used daily for long hours. Only a few are able to build safe exoskeleton products to perform independent movements. Yet balance is still a problem, meaning users still have to use crutches to be able to walk independently. Imagine you buy a several-hundred-thousand-worth device, but you still need to walk around with crutches, what is the purpose? The price is considered expensive because it cannot fully serve the needs of patients.

Consider it from a different angle: If the adoption of exoskeleton increases, the price will come down because of the economy of scale. We believe the price will eventually reduce to maybe US$55,000 or US$20,000, or even just a few thousand.

But if the economy of scale is not there, and there’s only a small quantity of usage, the price will not drop. So, it is like a vicious cycle, which together lead to low adoption rate. I think, in at least five to ten years, we will have a decent exoskeleton product that can serve the purpose of helping people work independently.

Q: What is your outlook for the industry?

A: In the past, foreign companies priced the device at around half a million U.S. dollars. In the future, I believe every single hospital, clinic, even small private clinic, and home-based therapist will be able to afford some forms of robotic devices to help them perform rehab and physical training tasks to achieve better results.

For Fourier, we hope to build our open platform, attracting an increasing number of clinicians, researchers, engineers, and even hobbyists to adopt our core technologies to develop more meaningful applications. We believe exoskeleton products eventually will become mainstream in three to five years. It is like air conditioners, washing machines, and smartphones, you will feel significantly inconvenient if you are deprived of it.

We hope to have intelligent machines that can interact with each other, send user data to the cloud and provide recommendations of solutions based on AI technology. They will become a great tool to help day-to-day tasks.

Q: Fourier Intelligence introduced a new product named “Fourier X2” in late January. What is special in the technologies adopted by it?

A: The new Fourier X2 is lighter, with better materials to make it more wearable. The application can be used in research, education, different augmentation application purposes, and industrial use.

Currently, the exoskeleton products in the Chinese market are passive, meaning users can only move in ways predetermined by programs of the exoskeleton equipment. The Fourier X2 has four senses in its self-developed active motion control system. We can understand the patients’ intention of movements to allow our machines to improve performances.

Q: The active motion control module applies enhanced algorithms to better handle the adjustment of users’ movement in real-time. Do you want to use artificial intelligence (AI) technology in the future?

A: Yes. They can be part of the machine learning after we have more data in the future. But as of now, the algorithms are used to optimize the controls including motion control and PID (proportional–integral–derivative) control.

Q: Will Fourier Intelligence develop other kinds of exoskeleton products in the future, like those in the Iron Man, which are used to augment human being’s physical strength?

A: Fourier focuses on the rehab and medical field. That’s why we are not venturing into robotics for other applications.

Q: Fourier raised a RMB30 million (US$4.44 million) series B round of financing in early 2018. How was the fundraising process?

A: It was smooth. We’re working on a new round of financing from three potential investors, hopefully to announce the completion of the new round latest by March or earliest by February. It is challenging during the current time as the expectation from investors is definitely higher.